Announcement on Key Financial Data of 1st Quarter of 2024
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Key Financial Data of 1st Quarter of 2024
Filed with SSE ·
Announcement on Key Financial Data of 1st Quarter of 2024
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
6ix hasn’t read this filing yet.
Earlier from BeOne Medicines
- Notice on Convening 2024 Annual General Meeting
- 2023 Annual Report
- Announcement on Voluntary Disclosure of European Commission's Approval of Baize'an (Tislelizumab Injection) for First-line and Second-line Treatment of Three Non-small Cell Lung Cancer Indications
- Announcement on Convening 2023 Annual Performance Meeting
- Announcement on Equity Registration Date of 2024 Annual General Meeting
Later from BeOne Medicines
- Announcement on Change of Senior Executive
- Announcement on Key Financial Data for the First Half Year of 2024
- Announcement on Convening Semi-annual Performance Briefing 2024
- Semi-annual Report in 2024
- Announcement on the Equity Registration Date for the 1st Extraordinary General Meeting (Shareholders' Special Meeting) in 2024
Follow BeOne Medicines into a list and get an email when it puts out news.
Follow BeOne Medicines